[Mechanisms and clinical research progress of mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease] [0.03%]
[间充质基质细胞治疗糖皮质激素难治性急性移植物抗宿主病的机制及临床研究进展]
N Wang,Z L Xu,D H Liu
N Wang
Acute graft-versus-host disease (aGVHD) is a common complication of allogeneic hematopoietic stem cell transplantation. The efficacy of standard first-line glucocorticoid treatment is limited; more than 40% of patients develop steroid-refra...
[Application of blinatumomab in adult acute B-lymphoblastic leukemia: a comprehensive strategy from remission induction to post-transplantation maintenance] [0.03%]
[Blinatumomab在成人急性B淋巴细胞白血病中的应用：从诱导缓解至移植后维持的综合策略]
X X Ma,E L Jiang
X X Ma
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important treatment option for adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) , and achieving complete remission (CR) is a critical step before...
[Indolent γδT-cell clone in Felty syndrome: a case report and literature review] [0.03%]
[Felty综合征中的惰性γδT细胞克隆1例报告及文献复习]
C Wang,M W Fu,G An et al.
C Wang et al.
The dynamic evolution of indolent γδT-cell clones in Felty syndrome (FS) and their relationship with progressive splenomegaly remain unclear. This paper reports a case of an FS patient followed for ten years. Serial assessments of γδT-c...
[CAR-T cell therapy bridging to allogeneic hematopoietic stem cell transplantation for diffuse large B-cell Richter syndrome: a case report and literature review] [0.03%]
[关于CAR-T细胞治疗桥接异基因造血干细胞移植治疗弥漫性大B细胞里德尔综合征1例及文献复习]
Y Wang,N Gao,Z Y Liu et al.
Y Wang et al.
This study aimed to explore the application of CAR-T cell therapy bridging to allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with diffuse large B-cell Richter syndrome, and to review recent advances in the diagno...
[Efficacy and safety of romiplostim N01 for refractory aplastic anemia: a retrospective single-center study] [0.03%]
罗米司亭治疗难治性再生障碍性贫血的疗效和安全性研究
Q L Zhuang,Z W Liu,C Yang et al.
Q L Zhuang et al.
Romiplostim N01 (QL0911) is a novel thrombopoietin receptor agonist (TPO-RA) ; however, clinical data regarding its efficacy and safety in patients with refractory aplastic anemia (AA) who have failed multiple prior lines of therapy are lim...
[Efficacy and safety of venetoclax-cytarabine-homoharringtonine-based cytoreductive therapy before allogeneic hematopoietic stem cell transplantation in refractory/relapsed acute myeloid leukemia with RUNX1::RUNX1T1: a retrospective study] [0.03%]
[用于易位型复发/难治性急性髓系白血病allo-HSCT前减积治疗的VTP方案疗效及安全性：一项回顾性研究]
Z L Zhang,C W Jin,S Li et al.
Z L Zhang et al.
Clinical data from five patients with refractory/relapsed acute myeloid leukemia (AML) and RUNX1::RUNX1T1 fusion gene, treated with venetoclax, cytarabine, and homoharringtonine-based cytoreductive therapy before allogeneic hematopoietic st...
[Clinical and genetic analysis of two families with combined defect in antithrombin and protein C genes] [0.03%]
抗凝血酶及蛋白C基因复合缺陷的家庭临床及基因分析
Y L Guo,T T Shan,W J Y Zheng et al.
Y L Guo et al.
Objective: To analyze the clinical characteristics and genetic mutations in two families with combined antithrombin (AT) and protein C (PC) deficiency, and to explore the relationship between combined SERPINC1 and PROC gene mutations and di...
[Bleeding characteristics in pregnant patients with immune thrombocytopenia and severe thrombocytopenia] [0.03%]
免疫性血小板减少症孕妇的出血特征分析
Y M Cheng,R X Li,Z H Feng et al.
Y M Cheng et al.
Objective: To evaluate whether the physiological hypercoagulable state of pregnancy affects the risk and severity of bleeding in pregnant patients with immune thrombocytopenia (ITP) and severe thrombocytopenia (PLT
[Construction and evaluation of a thrombosis risk prediction model in patients with primary immune thrombocytopenia] [0.03%]
原发免疫性血小板减少症患者血栓风险预测模型的构建及验证
J H Mao,L Wang,Y Shi et al.
J H Mao et al.
Objective: To analyze the risk factors for thrombosis in patients with primary immune thrombocytopenia (ITP) , construct a prediction model for thrombosis, and evaluate its performance. Methods: The clinical data of 334 ITP patients hospita...
[Efficacy and safety of basiliximab in gastrointestinal chronic graft-versus-host disease] [0.03%]
巴利昔单抗治疗胃肠慢性移植物抗宿主病的疗效及安全性分析
X L Zhu,J Z Wang,H X Fu et al.
X L Zhu et al.
Objective: To explore the efficacy and safety of basiliximab for gastrointestinal (GI) chronic graft-versus-host disease (cGVHD) . Methods: This was a retrospective case series. Patients who developed GI-cGVHD after transplantation at the P...